[theold]

Experts say that using the whole virus—as opposed to just the spike protein—may make this type of vaccine more effective against emerging variants.

Valneva’s vaccine trial was conducted at 26 sites in England with more than 4,000 participants and showed the shot to have comparable effectiveness to the AZ jab in protecting against the virus and with fewer side effects.

https://www.fiercepharma.com/pharma/late...-its-niche